"DRAXIN" Related Products

Expand

Recombinant Human DRAXIN Protein, His-tagged

Cat.No.: DRAXIN-745H
Product Overview: Recombinant human DRAXIN (NP_940947.3) (Met1-Val349) was expressed with a polyhistidine tag at the C-terminus.
Source: HEK293
Species: Human
Tag: His
Predicted N Terminal: Gly 26
Form: Lyophilized from sterile PBS, pH 7.4, 5% ~ 8% trehalose and mannitol.
Molecular Mass: The recombinant human DRAXIN consists of 335 amino acids and predicts a molecular mass of 37.5 KDa. It migrates as an approximately 52-58 KDa band in SDS-PAGE under reducing conditions.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Purity: >85 % as determined by SDS-PAGE
Stability: Samples are stable for up to twelve months from date of receipt at -70ºC.
Storage: Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 ug/ul. Centrifuge the vial at 4ºC before opening to recover the entire contents.
Gene Name: DRAXIN dorsal inhibitory axon guidance protein [ Homo sapiens ]
Official Symbol: DRAXIN
Synonyms: UNQ3119; neucrin; AGPA3119; C1orf187
Gene ID: 374946
mRNA Refseq: NM_198545.3
Protein Refseq: NP_940947.3
MIM: 612682
UniProt ID: Q8NBI3
Chromosome Location: 1p36.22

Online Inquiry

Note: There will be extra charge for optional service!
Optional requirements on this protein    +Expand
C-fusion    N-fusion   Non-tagged
His    GST   Fc   Others
<1.0 eu/μg    <0.1 eu/μg   <0.01 eu/μg   Not required
Monomer Isolation    Dimer Isolation    Not required
>80% by SDS-PAGE    >90% by SDS-PAGE   >95% by SDS-PAGE   Others

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information


Price does not include shipping and packaging costs.Request quote for final price.

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.